Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.77), $0.81 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $65 million versus the consensus estimate of $67.86 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.